HeartFlow was founded in 2007 by Charles Taylor and Christopher Zarins. HeartFlow has not officially endorsed a plan to participate in an IPO.
HeartFlow is a biotechnology company with a mission to treat cardiovascular diseases through machine learning algorithms. Per Forge data, HeartFlow has raised a total of $792.7 million in funding over 11 rounds. Their latest funding was raised on Apr 6, 2023, from a Series F round. Key investors include Panorama Point Partners, Capricorn Investment Group, and Bain Capital Life Sciences.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/13/2019 | Series E | $305MM | $xx.xx | $165.5B | Baillie Gifford, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
13,422,649
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Wellington Management
|
||||||
05/10/2016 | Series D | $99.93MM | $xx.xx | $77.17B | Bluecross Blueshield Venture Partners, Panorama Point Partners, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,151,873
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bluecross Blueshield Venture Partners, Panorama Point Partners, Undisclosed Investors
|
||||||
02/26/2014 | Series C | $104.7MM | $xx.xx | $37.34B | Capricorn Investment Group, Healthcor Management, Sandbox Industries, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
11,343,434
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Capricorn Investment Group, Healthcor Management, Sandbox Industries, Undisclosed Investors
|
||||||
02/04/2011 | Series B-2 | $10.11MM | $xx.xx | $9.01B | Ge Ventures, Healthcor Partners Management, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,848,263
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ge Ventures, Healthcor Partners Management, Undisclosed Investors
|
||||||
02/04/2011 | Series B-1 | $6.94MM | $xx.xx | $9.01B | Ge Ventures, Healthcor Partners Management, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,954,846
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ge Ventures, Healthcor Partners Management, Undisclosed Investors
|
||||||
04/16/2010 | Series A | $2.04MM | $xx.xx | $816.59MM | Bluecross Blueshield Venture Partners, Capricorn Healthcare, Emergent Medical Partners, Special Opportunities, U.S. Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,082,965
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bluecross Blueshield Venture Partners, Capricorn Healthcare, Emergent Medical Partners, Special Opportunities, U.S. Venture Partners
|